Deepa R. Pakianathan
Director
Infectious Diseases
PaxVax
Australia
Biography
Dr. Pakianathan is a Managing Member at Delphi Ventures, a venture capital firm focusing on healthcare investments. Prior to joining Dephi, Dr. Pakianathan served as a Vice President in the healthcare group at JP Morgan Chase & Company. Before joining JP Morgan, Dr. Pakianathan served as a postdoctoral scientist in the Immunology Department at Genentech, Inc. Dr. Pakianathan currently serves on the board of directors of Alder Biopharmaceuticals, Inc., OncoMed Pharmaceuticals, Inc. and Karyopharm Therapeutics, Inc. and NeurAxon. Dr. Pakianathan holds an M.S. and a Ph.D. from Wake Forest University, a B.Sc. from the University of Bombay, India and an M.Sc. from The Cancer Research Institute at the University of Bombay, India.
Research Interest
Dr. Pakianathan is a Managing Member at Delphi Ventures, a venture capital firm focusing on healthcare investments. Prior to joining Dephi, Dr. Pakianathan served as a Vice President in the healthcare group at JP Morgan Chase & Company. Before joining JP Morgan, Dr. Pakianathan served as a postdoctoral scientist in the Immunology Department at Genentech, Inc. Dr. Pakianathan currently serves on the board of directors of Alder Biopharmaceuticals, Inc., OncoMed Pharmaceuticals, Inc. and Karyopharm Therapeutics, Inc. and NeurAxon. Dr. Pakianathan holds an M.S. and a Ph.D. from Wake Forest University, a B.Sc. from the University of Bombay, India and an M.Sc. from The Cancer Research Institute at the University of Bombay, India.
